Guaranteed Buyout and Doubling of Funds if buy Myovant (MYOV)
The only thing certain in life is death and taxes – well add to that list the fact that Myovant is going to be bought out and when it does you’ll double your money. This isn’t some wishy washy bullshit oh it’s going to be bought out by big pharma since they have such a good product or such good potential, they are going to be bought out by a Japanese pharma company named Sumitomo it’s just a question of when. How can I be so sure? They already own 54% of the company which they acquired at the same time as 4 other companies that all end in vant and each of those 4 other companies is now fully owned with Urovant being the last one to be bought out at like 95% premium in the fall.
Should you trust me? Am I financial advisor – good god no but I am a doctor so maybe you should trust me but more so to remove whatever the fuck you have stuck up your ass rather than to give you stock tips. Does this sound a little like what Lipkissy posted a week ago? We work together and he made the kool aid and I drank it in believing in this company and you can’t lose.
What is it?
Their drug is a GNRH antagonist? What the fuck does that mean – fuck if I know I did med school 10 years ago but the end result is they can use the drug to treat prostate cancer in men or Uterine Fibroids or Endometriosis in women when sold as a combo drug with the birth control pill. Hormone sensitive Breast Cancer is the holy grail and should be in the offing to be studied soon which will rocket the stock.
Ready for Primetime?
They didn’t just do some shitty company sponsored study that is on their website, they have been published twice in the New England Journal of Medicine – kind of a big deal. They are already FDA approved for prostate cancer and will be approved for Uterine Fibroids before June 1 and then Endometriosis next year. Oh and did I mention that they just got approved this morning for fibroids in Europe – think FDA is going to delay?
Sell themselves at any cost?
Hell no. They got a $4.2 billion dollar partnership with Pfizer for half of their lead drug meaning that they will have the weight of Pfizer marketing and distributing it and it means they have the funds to continue on their own if they wanted. Added bonus – Pfizer’s big Prostate Cancer XTANDI has to be paired with this type of medication and its oral also – or I guess you could get your nuts lopped off but I think most people would rather have the pill.
This sucker ain’t going cheap. They are FDA approved for prostate cancer and the massive market of Uterine Fibroids is 2 weeks away with Endometriosis around the corner. Sumi owns 54% of the outstanding shares but isn’t allowed to buy the whole company without approval of a majority of the other shareholder who all know what this is worth. The non-SUMI board members all have to agree and guess who that includes – former HHS Secretary Kathleen Sebelius – not piece of shit pharma we have here. Going rate for takeovers is at least 100% premium and they have even ticked up to 130% in recent times.
Sumitomo Dainippon is a massive Japanese pharma with their best drug being the psych drug Latuda that is about to come off patent and they are shitting bricks. You don’t have to speak Japanese to read some DD on their IR site and see the genuine fear. No problem they have lots of cancer drugs in the pipeline with huge potential? Ha no such luck as they had 3 pretty high profile flops of their oncology drugs in a company where Treating Cancer is one of their 3 priorities – hmm if only they had this drug that could treat prostate cancer and literally save men’s lives by not having them die of heart attacks which is actually what is more likely to kill them than the cancer itself. Especially if they are on the dirty old injectable drug Lupron which Myovant’s drug absolutely crushed in the New England article.
Why buy now?
Ya you fucked up not getting it when it was like $17.50 dragged down by Biotech just utterly shitting a brick but this is still preposterously undervalued. MYOV had strong earnings last week and Sumi reported as well last week showing almost $2 billion in cash on hand a billion more than last year with R&D expenses going way down – whatever could they do with that cash? $44 a share wouldn’t even cost them that $2 billion and would lock this down. With June 1stFDA deadline for a decision on Fibroids the stock is primed to run up into that and shoot up post approval as the scripts start flowing in – remember this isn’t some shitty ass sales team this is the might of Pfizer behind them. And we got the Fibroids decision today for Europe and I can’t see America falling behind and letting them get the approval alone. FDA has been known to hand down early approval for drugs they’ve already approved in new indications like this one. Lots of money flowing in from these regulatory approvals triggering milestone payments and Pfizer might give them $50 mil more to license in Europe for prostate cancer at any point. It’s down today because of the market and quite literally the stupidest reason. FDA put a parital hold on their study evaluating if the combo drug prevents pregnancy until they monitor bone density – the solution: they will monitor bone density. That was its biggest advantage over competitors in their fibroid and endometriosis studies.
Kick ass product with pretty much guaranteed buyout that gets more expensive as the days go on – doesn’t that sound like incentive for them to get their ass in gear and make an offer. Even if they don’t Myovant has zero debt, zero risk of an offering, cash coming in left right and center and a hell of an opportunity to make a killing on their drugs. Truly can’t fucking lose. so why is it trading so cheap? Well cause no one knows about it, and the upside is only written down in Japanese.
via r/wallstreetbets https://ift.tt/3qhG8Zq
May 21, 2021 at 07:10AM